Annual and transition report of foreign private issuers pursuant to Section 13 or 15(d)

EQUITY (Narrative) (Details)

v3.24.1
EQUITY (Narrative) (Details)
$ / shares in Units, $ / shares in Units, ₪ in Thousands, $ in Thousands
 1 Months Ended 12 Months Ended
Mar. 14, 2022
CAD ($)
$ / shares
shares
Mar. 14, 2022
ILS (₪)
May 10, 2021
CAD ($)
Shares
shares
May 10, 2021
USD ($)
Shares
$ / shares
Feb. 28, 2023
CAD ($)
shares
Feb. 28, 2023
USD ($)
$ / shares
shares
Aug. 19, 2022
CAD ($)
shares
Aug. 19, 2022
USD ($)
shares
Mar. 28, 2022
CAD ($)
$ / shares
shares
Mar. 28, 2022
ILS (₪)
Dec. 31, 2023
CAD ($)
Shares
$ / shares
shares
Dec. 31, 2023
CAD ($)
Shares
$ / shares
shares
Dec. 31, 2022
CAD ($)
Shares
$ / shares
shares
Dec. 31, 2022
USD ($)
Shares
Dec. 31, 2021
CAD ($)
Mar. 28, 2022
$ / shares
shares
Mar. 14, 2022
$ / shares
shares
May 10, 2021
$ / shares
Disclosure of terms and conditions of share-based payment arrangement [line items]                                    
Number of shares issued | shares           1,159,999         13,394,136 13,394,136 7,569,526          
Proceeds from issuing shares                     $ 1,688,000   $ 3,756,000   $ 28,131,000      
Exercise price of warrants issued per common share | $ / shares       $ 7.2                            
Transaction costs incurred for common share issuance                     178,000   178,000   3,800,000      
Proceeds from exercise of warrants and compensation options                     $ 0   $ 0   3,682,000      
Weighted average value of each option grant | $ / shares                     $ 1.1   $ 10.85          
Number of share options exercised | Shares                     0   22,705 22,705        
Exercise price of compensation option | $ / shares                     $ 0   $ 16          
Number of share options granted | Shares                     3,000   32,503 32,503        
Share-based compensation                     $ 225,000   $ 2,637,000   5,422,000 [1]      
Number of compensation warrants to acquired | shares                     18,261 18,261            
Warrant price per share | (per share)                     $ 84.2 $ 66.1            
Private Placement [Member]                                    
Disclosure of terms and conditions of share-based payment arrangement [line items]                                    
Number of shares issued | shares             599,999 599,999                    
Proceeds from issuing shares                         $ 3,756,000 $ 3,000        
Transaction costs incurred for common share issuance             $ 178,000                      
Gross proceeds from issuance of units             $ 6,500,000 $ 5,000                    
Pharm Yarok [Member]                                    
Disclosure of terms and conditions of share-based payment arrangement [line items]                                    
Number of shares issued | shares 52,370                               52,370  
Par value per share | $ / shares $ 26.16                                  
Proceeds from issuing shares $ 1,370,000                                  
Vironna pharmacy [Member]                                    
Disclosure of terms and conditions of share-based payment arrangement [line items]                                    
Number of shares issued | shares 48,536                               48,536  
Par value per share | (per share) $ 28.09                               $ 22.09  
Proceeds from issuing shares $ 1,360,000 ₪ 3,500                                
Oranim Pharm [Member]                                    
Disclosure of terms and conditions of share-based payment arrangement [line items]                                    
Number of shares issued | shares                 25,100             25,100    
Par value per share | (per share)                 $ 25.1             $ 19.74    
Proceeds from issuing shares                 $ 600,000 ₪ 1,536                
Overnight Marketed Offering [Member]                                    
Disclosure of terms and conditions of share-based payment arrangement [line items]                                    
Number of shares issued | shares     608,696                              
Par value per share | $ / shares                                   $ 57.5
Proceeds from issuing shares     $ 42,000,000 $ 35,000                            
Number of warrants issued for common shares | Shares     45,652 45,652                            
Expenses for share based compensation     $ 800,000                              
Number of share options granted | Shares     91,304 91,304                            
Life Offering [Member]                                    
Disclosure of terms and conditions of share-based payment arrangement [line items]                                    
Number of shares issued | shares           2,828,248                        
Par value per share | $ / shares           $ 1.25                        
Proceeds from issuing shares         $ 4,792,000 $ 3,535                        
Exercise price of warrants issued per common share | $ / shares           $ 1.5                        
Term of warrants         36 months 36 months                        
Number Of Shared Subscribed | shares         131,700 131,700                        
Value Of Shared Subscribed         $ 224,000 $ 165                        
Concurrent Offering [Member]                                    
Disclosure of terms and conditions of share-based payment arrangement [line items]                                    
Number of shares issued | shares           2,317,171                        
Par value per share | $ / shares           $ 1.25                        
Proceeds from issuing shares         $ 3,926,000 $ 2,896                        
2021 Warrant [Member]                                    
Disclosure of terms and conditions of share-based payment arrangement [line items]                                    
Number of warrants issued for common shares | Shares     304,348 304,348                            
Exercise price of warrants issued per common share | $ / shares       $ 7.2                            
Number of common shares called by warrants | shares     304,348                              
Term of warrants     5 years 5 years                            
Gross proceeds from warrants recorded as Share capital and premium     $ 30,670,000                              
Warrant liability     11,832,000                              
Transaction costs incurred for common share issuance     3,800,000                              
Number of warrants outstanding | Shares                     6,063,960 6,063,960 304,348          
Fair value of warrants                     $ 38,000 $ 38,000 $ 8,000          
(Gain) loss on revaluation                     6,955,000   6,014,000   5,810,000      
2021 Warrant [Member] | Listed Warrants [Member]                                    
Disclosure of terms and conditions of share-based payment arrangement [line items]                                    
Transaction costs incurred for common share issuance     1,296,000                              
2021 Warrant [Member] | Share Capital [Member]                                    
Disclosure of terms and conditions of share-based payment arrangement [line items]                                    
Transaction costs incurred for common share issuance     $ 2,539,000                              
2018 Share Incentive Plan" (the "2018 Plan") [Member]                                    
Disclosure of terms and conditions of share-based payment arrangement [line items]                                    
Share-based compensation                     $ 225,000   2,637,000   5,422,000      
Number of shares available for future grants | shares                     746,352              
Weighted average fair value of each option grant                     $ 28.2 $ 28.2 $ 31.9   $ 41.6      
Weighted average remaining contractual life for the share options outstanding                     3 years 9 months 3 days   4 years 3 months 25 days 4 years 3 months 25 days        
2018 Share Incentive Plan" (the "2018 Plan") [Member] | Vest on the first anniversary of the applicable vesting commencement date [Member]                                    
Disclosure of terms and conditions of share-based payment arrangement [line items]                                    
Awards vest                     33.30%              
2018 Share Incentive Plan" (the "2018 Plan") [Member] | Vest in eight equal installments upon the lapse of each three-month period thereafter [Member]                                    
Disclosure of terms and conditions of share-based payment arrangement [line items]                                    
Awards vest                     66.70%              
[1] Reclassified in respect of discontinued operations - see Note 25.